Chronic Stable Angina Flashcards

(44 cards)

1
Q

What therapy should not be initiated in patients with SIHD?

A

Therapy with rosiglitazone

Level of Evidence: C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a reasonable A1C goal for patients with a short duration of diabetes and a long life expectancy?

A

7% or less

Level of Evidence B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What should high-risk patients with SIHD and diabetes mellitus be prescribed?

A

An ACE inhibitor

Supported by HOPE and EUROPA studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is recommended for a hypertensive patient with SIHD?

A

Treatment with an ACE inhibitor

Level of Evidence A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is empagliflozin considered a first-line treatment for hyperglycemia?

A

No

It reduces blood pressure, hyperglycemia, and MACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the gold standard for the diagnosis of CAD?

A

Coronary angiography

Despite limitations in grading stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do IVUS and OCT provide compared to angiography?

A

More precise information about stenosis severity and plaque morphology

Useful in assessing coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Class IIa indications for hybrid coronary revascularization?

A

Limitations to traditional CABG, lack of suitable graft conduits, unfavorable LAD artery for PCI

Hybrid revascularization aims to improve the risk–benefit ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What characterizes significant clinical stenosis in left main stenoses?

A

≥50% luminal diameter narrowing

In the worst view angiographic projection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What defines significant stenosis in other locations aside from the left main?

A

≥70% luminal diameter narrowing

Intermediate lesions with FFR ≤ 0.80 are also significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does FFR reveal about an intermediate LAD lesion?

A

It may be functionally significant

Indicates two-vessel disease without left-main or proximal LAD disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mortality benefit of revascularization in unprotected left main disease?

A

There is a mortality benefit from revascularization

Evidence supports improved mortality with PCI relative to CABG in low complexity cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the indication for PCI in single-vessel proximal circumflex vessel disease?

A

To improve symptoms

Mortality benefits are not established for all cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the SYNTAX score assess?

A

Complexity of coronary artery disease

Low complexity scores are associated with isolated left main or adjunctive single vessel disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the outcomes of FFR measurements in vein grafts?

A

Data on the use of FFR in vein grafts are limited

FFR is well validated in native vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the next appropriate step for a patient whose symptoms do not meet criteria for typical angina?

A

Consider noninvasive stress testing

Exercise ECG is recommended due to low pretest probability of CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What did the BARI study demonstrate regarding angioplasty and bypass grafting?

A

Equivalent long-term survival among patients with multivessel disease

Superior survival with internal mammary grafts to LAD artery in diabetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the general recommendation for CABG vs. PCI for diabetics with multivessel disease?

A

CABG is generally preferred

Supported by ACC and AHA guidelines

19
Q

What is the clinical benefit of revascularization in patients with nonviable myocardium?

A

Limited clinical benefit

Patients with viable myocardium had better outcomes when revascularized

20
Q

What is the indication for revascularization in one-vessel disease without proximal LAD involvement?

A

Revascularization is harmful

ACC/AHA Class III recommendation

21
Q

What is the recommendation for revascularization in patients with one-vessel disease without proximal LAD involvement?

A

Harmful (ACC/AHA Class III)

22
Q

In patients with two-vessel disease without proximal LAD involvement or extensive ischemia, what is the revascularization recommendation?

A

Uncertain benefit (ACC/AHA Class IIb)

23
Q

When is revascularization not indicated?

A

If the patient has not received an adequate trial of medical therapy and has no demonstrable evidence of ischemia

24
Q

What is the appropriate therapy for patients with CAD who have not received adequate medical therapy?

A

Guideline directed medical therapy with a statin

25
What were the findings of randomized trials comparing stenting or CABG in patients with multivessel disease?
Equivalent long-term survival observed
26
What demographic typically characterized patients in randomized trials of stenting or CABG?
Relatively young (age 60 years) with two-vessel disease and preserved ventricular function
27
What did the cost-effectiveness analysis of the BARI trial demonstrate?
Cost-effectiveness of CABG compared to angioplasty
28
In the context of PCI for left main lesions, what is the current guideline recommendation?
Favor CABG over PCI in suitable patients
29
What was a major determinant of outcome in comparing CABG to PCI in the SYNTAX study?
Complexity of disease
30
What is the ACC/AHA recommendation for revascularization of left main disease with PCI?
Upgraded from Class III to Class IIb when anatomy is suitable
31
What is the relationship between creatine kinase (CK) rise and adverse outcomes?
Linear relationship demonstrated
32
What troponin elevation level is associated with increased mortality?
Marked elevations (>5 times normal)
33
What did the MASS study demonstrate regarding survival for patients with LAD disease?
Comparable survival regardless of treatment (medical therapy, PCI, CABG)
34
What does the COURAGE study indicate about PCI vs. intense medical therapy?
Comparable outcomes in stable patients over 15 years
35
What is the recommendation for asymptomatic patients with high-risk features on nuclear stress study?
Coronary angiography for risk stratification
36
What is recommended for patients with a normal ECG and no prior MI?
Routine assessment of left ventricular function is not recommended (Class III)
37
What does a Duke treadmill score of +7 suggest?
Low annual risk of cardiovascular events (<1% per year)
38
What is the significance of a lesion with ≥50% luminal diameter narrowing?
Suggestive of functional significance
39
What is recommended for patients with significant left main disease?
CABG is recommended (Class I)
40
What is the recommended approach to stress testing after revascularization?
Stress testing with adjunctive imaging is recommended
41
What is the occlusion rate of SVGs within the first year after surgery?
Up to 22%
42
What is the occlusion rate of SVGs over 10 years?
40%
43
What is the recommendation regarding hormone replacement therapy for postmenopausal women?
Not recommended due to potential harm (Class IV)
44
What was the finding of the study regarding Vitamin E in cardiovascular event reduction?
Not found to be beneficial (Class III)